SCHEMBL31728686

SCHEMBL31728686

O=S(=O)(c1cccc(N2CCC(CO)CC2)c1)N1CCCCC1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.53
NPSR1 Q6W5P4 2/20 0.53
SMN1; SMN2 Q16637 6/20 0.53
LMNA P02545 3/20 0.51
TSHR P16473 2/20 0.51
THRB P10828 1/20 0.51
HTT P42858 4/20 0.51
POLB P06746 1/20 0.51
GAA P10253 1/20 0.50
HSD17B10 Q99714 1/20 0.49
MAPT P10636 2/20 0.49
IL1RN P18510 1/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
MITF O75030 1/20 0.47
NOD2 Q9HC29 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7131785 0.84 MAPT (0.58) ALDH1A1SMN1; SMN2LMNATSHRHTT
SCHEMBL31726402 0.83 HTR6 (0.45) SMN1; SMN2THRBHTTMEN1KMT2A
SCHEMBL31729372 0.83 POLB (0.55) ALDH1A1SMN1; SMN2LMNATSHRPOLB
Hydrochloric Acid SCHEMBL31322341 0.80 HTR6 (0.66) ALDH1A1NPSR1SMN1; SMN2LMNATSHR
SCHEMBL30915026 0.77 GPR119 (0.51) ALDH1A1SMN1; SMN2TSHRKMT2A
SCHEMBL31619968 0.77 GPR119 (0.51) ALDH1A1SMN1; SMN2TSHRKMT2A
SCHEMBL4294798 0.76 L3MBTL1 (0.64) ALDH1A1SMN1; SMN2TSHRHTTPOLB
SCHEMBL3931238 0.74 MAPT (0.70) ALDH1A1SMN1; SMN2LMNATSHRHTT
SCHEMBL1002282 0.74 ALDH1A1 (0.61) ALDH1A1NPSR1SMN1; SMN2LMNATSHR
SCHEMBL10127682 0.73 ADRA2C (0.53) ALDH1A1SMN1; SMN2LMNAMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235298-A1 BIFUNCTIONAL COMPOUNDS CONTAINING THIAZOLYL DERIVATIVES FOR DEGRADING CERTAIN CYCLIN-DEPENDENT KINASE VIA UBIQUITIN PROTEASOME PATHWAY NIKANG THERAPEUTICS, INC. (US) 2025-11-13 WO disclosed
WO-2025235331-A1 BIFUNCTIONAL COMPOUNDS CONTAINING PYRAZOLOPYRIMIDINE DERIVATIVES FOR DEGRADING CERTAIN CYCLIN-DEPENDENT KINASE VIA UBIQUITIN PROTEASOME PATHWAY NIKANG THERAPEUTICS, INC. (US) 2025-11-13 WO disclosed